REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.80
Bid: 361.60
Ask: 362.00
Change: 2.80 (0.78%)
Spread: 0.40 (0.111%)
Open: 357.00
High: 364.80
Low: 357.00
Prev. Close: 360.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

20 Feb 2024 07:00

RNS Number : 6754D
QinetiQ Group plc
20 February 2024
 

QinetiQ Group plc

20th February 2024

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that on 16th February 2024 it has purchased, in accordance with the authority granted by shareholders at the general meeting of the Company held on 6 February 2024, the following number of its ordinary shares of 1 pence each (Shares) on the London Stock Exchange pursuant to its existing £100 million share buyback programme which was announced on 16 January 2024.

The Company intends to cancel the purchased shares.

Description of Shares:

QinetiQ Group plc- ordinary shares of 1 pence each (ISIN: GB00B0WMWD03)

Date of transaction

19th February 2024

Number of Shares purchased:

119,827

Average price paid per Share (pence):

376.6669

Highest price paid per Share (pence):

378.0000

Lowest price paid per Share (pence):

374.6000

Broker:

Barclays Capital Securities Limited

 

Aggregate information:

Venue

Volume-weighted average price

Aggregated volume

Lowest price per share

Highest price per share

Aquis Exchange

3.7684

12,534

3.7580

3.7780

CBOE BXE

3.7682

8,803

3.7620

3.7780

CBOE CXE

3.7670

27,422

3.7500

3.7800

London Stock Exchange

3.7659

62,954

3.7460

3.7800

Turquoise

3.7670

8,114

3.7640

3.7680

 

This announcement is prepared on a trade basis. It is expected the shares purchased will be delivered to the Company within two working days. The total voting rights referred to below is prepared on a settlement basis.

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 577,597,294. The Company does not hold any ordinary shares in treasury. Therefore, the total voting rights in the Company will be 577,597,294.

The figure of 577,597,294 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/6754D_1-2024-2-19.pdf

This announcement will also be available on QinetiQ Group plc's website at https://www.qinetiq.com/en/investors.

Enquiries to:

John Haworth, Group Head of Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKCBPOBKDFBD
Date   Source Headline
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding
20th Aug 20202:14 pmRNSHolding(s) in Company
13th Aug 20204:47 pmRNSDirector/PDMR Shareholding
11th Aug 202011:56 amRNSDirector/PDMR Shareholding
10th Aug 202011:28 amRNSTotal Voting Rights
4th Aug 20203:59 pmRNSBlock Listing Application
31st Jul 202012:50 pmRNSTransfer of Treasury Shares & Total Voting Rights
14th Jul 20202:00 pmRNSResult of Annual General Meeting
14th Jul 20207:00 amRNSQ1 Trading Update and Acquisition of Naimuri
13th Jul 20203:51 pmRNSQinetiQ enters next phase of growth in the US
10th Jul 202011:52 amRNSDirector/PDMR Shareholding
1st Jul 202010:50 amRNSDirector/PDMR Shareholding
1st Jul 202010:49 amRNSTotal Voting Rights
1st Jul 202010:46 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSDisposal of Boldon James to HelpSystems
23rd Jun 202011:46 amRNSDirector/PDMR Shareholding
12th Jun 202010:48 amRNSAnnual Financial Report
10th Jun 202012:31 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSPreliminary Results
19th May 20204:05 pmRNSDirectorate Change
12th May 202011:22 amRNSDirector/PDMR Shareholding
1st May 202011:16 amRNSBlock listing Interim Review
30th Apr 20207:00 amRNSAppointment of Broker
29th Apr 20204:17 pmRNSHolding(s) in Company
15th Apr 202010:35 amRNSDirector/PDMR Shareholding
1st Apr 20209:33 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading and COVID-19 update
20th Mar 202010:21 amRNSDirector/PDMR Shareholding
18th Mar 20202:13 pmRNSHolding(s) in Company
10th Mar 202011:13 amRNSDirector/PDMR Shareholding
11th Feb 202010:53 amRNSDirector/PDMR Shareholding
10th Feb 202012:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.